Banner
Global Pharmacogenetic Testing Market Report 2024

Pharmacogenetic Testing Global Market Report 2024 – By Type (Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests), By Drug Type (Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications), By Therapeutic Area (Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas), By Distribution Channel (Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services), By End User (Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

Pharmacogenetic Testing Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : November 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Global Pharmacogenetic Testing Market Infographic

Proud Members Of

checkslacipN checkaoirsN checkscipN

Pharmacogenetic Testing Market Definition

Pharmacogenetic testing is a type of genetic testing that examines how an individual's genetic makeup influences their response to specific medications, helping to tailor drug treatments for better efficacy and reduced side effects. This personalized approach enhances patient care by tailoring therapies based on genetic profiles. It is widely used in fields such as oncology, psychology, and cardiology.

The main types of pharmacogenetic testing are whole genome sequencing, whole exome sequencing, array-based tests, and single gene tests. Whole genome sequencing is a comprehensive method for analyzing the entire genome of an organism. It involves sequencing all of the DNA in a single test, providing a complete picture of an individual's genetic makeup. Droug type includes prescription drugs, nutraceuticals, recreational drugs, herbal supplements, vitamins, and over-the-counter medications for different therapeutic areas such as cardiology, gastroenterology, anesthesiology, genomics, endocrinology, immunology and hypersensitivity, dermatology, gynecology, oncology, and others. These are distributed through hospital pharmacies, retail pharmacies, mail-order pharmacies, and direct-to-customer services and are used by various end users, such as healthcare providers, pharmaceutical and biotechnology companies, centers and academic institutes, and others.

Pharmacogenetic Testing Market Segmentation

The pharmacogenetic testing market covered in this report is segmented –

1) By Type: Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests

2) Drug Type: Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications

3) Therapeutic Area: Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services

5) By End User: Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End Users

Global Pharmacogenetic Testing Market Size 2023 to 2028: Graph

Pharmacogenetic Testing Market Size 2024 And Growth Rate

The pharmacogenetic testing market size has grown rapidly in recent years. It will grow from $10.68 billion in 2023 to $12.37 billion in 2024 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to increasing overall drug efficacy, increasing adoption of personalized medicine, growing need for precision diagnosis, increasing focus on pharmacogenetic testing, and increasing medical expenses.

Pharmacogenetic Testing Market Growth Forecast

The pharmacogenetic testing market size is expected to see rapid growth in the next few years. It will grow to $22.28 billion in 2028 at a compound annual growth rate (CAGR) of 15.9%. The growth in the forecast period can be attributed to rising research and development associated with biotechnology and healthcare, increasing healthcare expenditure, rising prevalence Of chronic diseases, increased accessibility, rise of telemedicine and digital health. Major trends in the forecast period include pharmacogenetic testing, advancements in genomic technologies, technological advancements, advances in companion diagnostics, and innovative diagnostic tests.

Pharmacogenetic Testing Market Driver: Impact Of Personalized Medicine On The Growth Of The Pharmacogenetic Testing Market

The increasing demand for personalized medicine is expected to propel the growth of the pharmacogenetic testing market going forward. Personalized medicine, also known as precision medicine, is a medical approach that tailors healthcare decisions and treatments to the individual characteristics of each patient. The increasing personalized medicine is due to several factors, such as improved treatment outcomes, a focus on prevention and early detection, and cost-effectiveness. Pharmacogenetic testing is integral to personalized medicine by analyzing an individual's genetic makeup to predict how they will respond to specific medications. This enables healthcare providers to tailor treatments based on genetic factors, optimizing drug efficacy and minimizing adverse reactions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Therefore, the increasing demand for personalized medicine is driving the growth of the pharmacogenetic testing market.

Global Pharmacogenetic Testing Market Major Players

Major companies operating in the pharmacogenetic testing market are CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, RxGenomix LLC

Global Pharmacogenetic Testing Market Trend: Advancements In Prescription-Based Pharmacogenetic Testing

Major companies operating in the pharmacogenetics testing market are developing advanced pharmacogenomics testing services, such as prescription-based pharmacogenetic testing, to gain a competitive edge in the market. Prescription-based pharmacogenetic testing refers to genetic tests that are specifically ordered or prescribed by healthcare providers to analyze a patient's genetic makeup before prescribing medications. For instance, in May 2023, UCSF, a US-based healthcare company, launched its pharmacogenomics testing service. It is designed to improve the precision of medical treatments. UCSF's pharmacogenomics testing service helps healthcare providers tailor drug therapies based on an individual's genetic profile, aiming to enhance drug efficacy, minimize adverse reactions, and support personalized medicine strategies.

Pharmacogenetic Testing Market Merger And Acquisition: HealthOme Expands Genetic Testing And Personalized Medicine With Kailos Genetics Acquisition

In May 2023, HealthOme, a US-based company that specializes in manufacturing advanced genetic testing and personalized medicine solutions, acquired Kailos Genetics for an undisclosed amount. HealthOme's acquisition of Kailos Genetics is intended to enhance its genetic testing and personalized medicine offerings by incorporating Kailos Genetics' advanced genomic technologies and expertise. Kailos Genetics is a US-based company that provides comprehensive pharmacogenetic testing services through its Inspexion platform.

Regional Insights For The Global Pharmacogenetic Testing Market

Asia-Pacific was the largest region in the pharmacogenetic testing market in 2023 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmacogenetic testing market report areAustralia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmacogenetic testing market consists of revenues earned by entities by providing services such as predicting drug efficacy, guiding dosage selection, and preventing adverse drug reactions. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmacogenetic testing market also includes sales of gene panels, deoxyribonucleic acid (DNA) sequencers, and home testing kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The pharmacogenetic testing market research report is one of a series of new reports from The Business Research Company that provides pharmacogenetic testing market statistics, including pharmacogenetic testing industry global market size, regional shares, competitors with a pharmacogenetic testing market share, detailed pharmacogenetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacogenetic testing industry. This pharmacogenetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pharmacogenetic Testing Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2024 $12.37 billion
Revenue Forecast In 2033 $22.28 billion
Growth Rate CAGR of 15.9% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Whole Genome Sequencing; Whole Exome Sequencing; Array-Based Tests; Single Gene Tests
2) By Drug Type: Prescription Drugs; Nutraceuticals; Recreational Drugs; Herbal Supplements; Vitamins; Over-The-Counter Medications
3) By Therapeutic Area: Cardiology; Gastroenterology; Anesthesiology; Genomics; Endocrinology; Immunology And Hypersensitivity; Dermatology; Gynecology; Oncology; Other Therapeutic Areas
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacies; Mail-Order Pharmacies; Direct-to-Customer Services
5) By End User: Healthcare Providers; Pharmaceutical And Biotechnology Companies; Centers And Academic Institutes; Other End Users
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, RxGenomix LLC
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Pharmacogenetic Testing Market Characteristics

    3. Pharmacogenetic Testing Market Trends And Strategies

    4. Pharmacogenetic Testing Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Pharmacogenetic Testing Market Size and Growth

    5.1. Global Pharmacogenetic Testing Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Pharmacogenetic Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Pharmacogenetic Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Pharmacogenetic Testing Market Segmentation

    6.1. Global Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Whole Genome Sequencing

    Whole Exome Sequencing

    Array-Based Tests

    Single Gene Tests

    6.2. Global Pharmacogenetic Testing Market, Segmentation Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Prescription Drugs

    Nutraceuticals

    Recreational Drugs

    Herbal Supplements

    Vitamins

    Over-The-Counter Medications

    6.3. Global Pharmacogenetic Testing Market, Segmentation Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Cardiology

    Gastroenterology

    Anesthesiology

    Genomics

    Endocrinology

    Immunology And Hypersensitivity

    Dermatology

    Gynecology

    Oncology

    Other Therapeutic Areas

    6.4. Global Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital Pharmacy

    Retail Pharmacies

    Mail-Order Pharmacies

    Direct-to-Customer Services

    6.5. Global Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Healthcare Providers

    Pharmaceutical And Biotechnology Companies

    Centers And Academic Institutes

    Other End Users

    7. Pharmacogenetic Testing Market Regional And Country Analysis

    7.1. Global Pharmacogenetic Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Pharmacogenetic Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Pharmacogenetic Testing Market

    8.1. Asia-Pacific Pharmacogenetic Testing Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Pharmacogenetic Testing Market

    9.1. China Pharmacogenetic Testing Market Overview

    9.2. China Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Pharmacogenetic Testing Market

    10.1. India Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Pharmacogenetic Testing Market

    11.1. Japan Pharmacogenetic Testing Market Overview

    11.2. Japan Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Pharmacogenetic Testing Market

    12.1. Australia Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Pharmacogenetic Testing Market

    13.1. Indonesia Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Pharmacogenetic Testing Market

    14.1. South Korea Pharmacogenetic Testing Market Overview

    14.2. South Korea Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Pharmacogenetic Testing Market

    15.1. Western Europe Pharmacogenetic Testing Market Overview

    15.2. Western Europe Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Pharmacogenetic Testing Market

    16.1. UK Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Pharmacogenetic Testing Market

    17.1. Germany Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Pharmacogenetic Testing Market

    18.1. France Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Pharmacogenetic Testing Market

    19.1. Italy Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Pharmacogenetic Testing Market

    20.1. Spain Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Pharmacogenetic Testing Market

    21.1. Eastern Europe Pharmacogenetic Testing Market Overview

    21.2. Eastern Europe Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Pharmacogenetic Testing Market

    22.1. Russia Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Pharmacogenetic Testing Market

    23.1. North America Pharmacogenetic Testing Market Overview

    23.2. North America Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Pharmacogenetic Testing Market

    24.1. USA Pharmacogenetic Testing Market Overview

    24.2. USA Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Pharmacogenetic Testing Market

    25.1. Canada Pharmacogenetic Testing Market Overview

    25.2. Canada Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Pharmacogenetic Testing Market

    26.1. South America Pharmacogenetic Testing Market Overview

    26.2. South America Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Pharmacogenetic Testing Market

    27.1. Brazil Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Pharmacogenetic Testing Market

    28.1. Middle East Pharmacogenetic Testing Market Overview

    28.2. Middle East Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Pharmacogenetic Testing Market

    29.1. Africa Pharmacogenetic Testing Market Overview

    29.2. Africa Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Pharmacogenetic Testing Market Competitive Landscape And Company Profiles

    30.1. Pharmacogenetic Testing Market Competitive Landscape

    30.2. Pharmacogenetic Testing Market Company Profiles

    30.2.1. CVS Health Corporation

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Thermo Fisher Scientific Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Quest Diagnostics Incorporated

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Eurofins Scientific Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Bio-Rad Laboratories

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Pharmacogenetic Testing Market Other Major And Innovative Companies

    31.1. Precision Medicine Advsiors

    31.2. Azenta Life Sciences

    31.3. Fulgent Genetics

    31.4. Pacific Biosciences of California Inc.

    31.5. Castle Biosciences

    31.6. 23andMe Holding Co.

    31.7. Helix Inc.

    31.8. Genomind Inc.

    31.9. MD Labs

    31.10. Sonic Genetics

    31.11. AutoGenomics Inc.

    31.12. LabClinics SA

    31.13. Gene By Gene Ltd.

    31.14. Xcode Life Sciences

    31.15. YouScript

    32. Global Pharmacogenetic Testing Market Competitive Benchmarking

    33. Global Pharmacogenetic Testing Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Pharmacogenetic Testing Market

    35. Pharmacogenetic Testing Market Future Outlook and Potential Analysis

    35.1 Pharmacogenetic Testing Market In 2028 - Countries Offering Most New Opportunities

    35.2 Pharmacogenetic Testing Market In 2028 - Segments Offering Most New Opportunities

    35.3 Pharmacogenetic Testing Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Pharmacogenetic Testing Market, Segmentation Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Pharmacogenetic Testing Market, Segmentation Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Pharmacogenetic Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Global Pharmacogenetic Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: Asia-Pacific, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: China, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: India, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Japan, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Australia, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: Indonesia, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: South Korea, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: Western Europe, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: UK, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: Germany, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: France, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Italy, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Spain, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Eastern Europe, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: Russia, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: North America, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: USA, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: Canada, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: South America, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Brazil, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Middle East, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Africa, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 76: CVS Health Corporation Financial Performance
  • Table 77: Thermo Fisher Scientific Inc. Financial Performance
  • Table 78: Quest Diagnostics Incorporated Financial Performance
  • Table 79: Eurofins Scientific Inc. Financial Performance
  • Table 80: Bio-Rad Laboratories Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Pharmacogenetic Testing Market, Segmentation Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Pharmacogenetic Testing Market, Segmentation Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Pharmacogenetic Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Global Pharmacogenetic Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: Asia-Pacific, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: China, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: India, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Japan, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Australia, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: Indonesia, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: South Korea, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: Western Europe, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: UK, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: Germany, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: France, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Italy, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Spain, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Eastern Europe, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: Russia, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: North America, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: USA, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: Canada, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: South America, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Brazil, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Middle East, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Africa, Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 76: CVS Health Corporation Financial Performance
  • Figure 77: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 78: Quest Diagnostics Incorporated Financial Performance
  • Figure 79: Eurofins Scientific Inc. Financial Performance
  • Figure 80: Bio-Rad Laboratories Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the pharmacogenetic testing market?

Pharmacogenetic testing is a type of genetic testing that examines how an individual's genetic makeup influences their response to specific medications, helping to tailor drug treatments for better efficacy and reduced side effects. This personalized approach enhances patient care by tailoring therapies based on genetic profiles. It is widely used in fields such as oncology, psychology, and cardiology. For further insights on the pharmacogenetic testing market, request a sample here

How will the pharmacogenetic testing market drivers and restraints affect the pharmacogenetic testing market dynamics? What forces will shape the pharmacogenetic testing industry going forward?

The pharmacogenetic testing market major growth driver - Impact Of Personalized Medicine On The Growth Of The Pharmacogenetic Testing Market. For further insights on the pharmacogenetic testing market, request a sample here

What is the forecast market size or the forecast market value of the pharmacogenetic testing market?

The pharmacogenetic testing market size has grown rapidly in recent years. It will grow from $10.68 billion in 2023 to $12.37 billion in 2024 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to increasing overall drug efficacy, increasing adoption of personalized medicine, growing need for precision diagnosis, increasing focus on pharmacogenetic testing, and increasing medical expenses. The pharmacogenetic testing market size is expected to see rapid growth in the next few years. It will grow to $22.28 billion in 2028 at a compound annual growth rate (CAGR) of 15.9%. The growth in the forecast period can be attributed to rising research and development associated with biotechnology and healthcare, increasing healthcare expenditure, rising prevalence Of chronic diseases, increased accessibility, rise of telemedicine and digital health. Major trends in the forecast period include pharmacogenetic testing, advancements in genomic technologies, technological advancements, advances in companion diagnostics, and innovative diagnostic tests. For further insights on the pharmacogenetic testing market, request a sample here

How is the pharmacogenetic testing market segmented?

The pharmacogenetic testing market is segmented
1) By Type: Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests
2) Drug Type: Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications
3) Therapeutic Area: Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services
5) By End User: Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End UsersFor further insights on the pharmacogenetic testing market,
request a sample here

Which region has the largest share of the pharmacogenetic testing market? What are the other regions covered in the report?

Asia-Pacific was the largest region in the pharmacogenetic testing market in 2023 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the pharmacogenetic testing market, request a sample here.

Who are the major players in the pharmacogenetic testing market?

Major companies operating in the pharmacogenetic testing market are CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, RxGenomix LLC For further insights on the pharmacogenetic testing market, request a sample here.

What are the key trends in the pharmacogenetic testing market?

Major trend in the pharmacogenetic testing market - Advancements In Prescription-Based Pharmacogenetic Testing. For further insights on the pharmacogenetic testing market, request a sample here.

What are the major opportunities in the pharmacogenetic testing market? What are the strategies for the pharmacogenetic testing market?

For detailed insights on the major opportunities and strategies in the pharmacogenetic testing market, request a sample here.

How does the pharmacogenetic testing market relate to the overall economy and other similar markets?

For detailed insights on pharmacogenetic testing market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the pharmacogenetic testing industry?

For detailed insights on the mergers and acquisitions in the pharmacogenetic testing industry, request a sample here.

What are the key dynamics influencing the pharmacogenetic testing market growth? SWOT analysis of the pharmacogenetic testing market.

For detailed insights on the key dynamics influencing the pharmacogenetic testing market growth and SWOT analysis of the pharmacogenetic testing industry, request a sample here.